Microarray studies of prognostic stratification and transformation of follicular lymphomas

Best Practice and Research: Clinical Haematology

Volumn 18, Issue 1 SPEC. ISS., 2005, Pages 143-156

  Sigal, Shaklai ^a   Ninette, Amariglio ^a   Rechavi, Gideon ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Follicular lymphoma; Microarray; Prognosis; Transformation

Indexed keywords

CYCLIN DEPENDENT KINASE 2; DNA; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GROWTH FACTOR; MYC PROTEIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN BCL 2; PROTEIN BCL 6; PROTEIN P53; RAS PROTEIN; SCATTER FACTOR RECEPTOR;

B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER RESEARCH; CARCINOGENESIS; CHROMOSOME 14Q; CHROMOSOME 17P; CHROMOSOME 3Q; CHROMOSOME 9P; CHROMOSOME TRANSLOCATION 14; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE ASSOCIATION; DISEASE COURSE; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ANALYSIS; HUMAN; INDIVIDUALIZATION; MALIGNANT TRANSFORMATION; MOLECULAR MECHANICS; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 13344295066     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2004.08.018     Document Type: Review

References (80)

1. J.O. Armitage & D.D. Weisenburger New approaches to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin's lymphoma classification project J. Clin. Oncol. 16 1998 2780-2795
2. S.J. Horning & S.A. Rosenberg The natural history of initially untreated low-grade non-Hodgkin's lymphomas N. Engl. J. Med. 3 11 1984 1471-1475
3. T.J. McDonell N. Dean F.M. Platt et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation Cell 57 1989 79-88
4. B. Acker R.T. Hoppe T.V. Colby et al. Histologic conversion in the non-Hodgkin's lymphomas J. Clin. Oncol. 1 1983 11-16
5. J. Ersboll H.B. Schultz J. Pederson-Bjergaard et al. Follicular low-grade non- Hodgkins's lymphoma: Long term outcome with or without tumor progression Eur. J. Haematol. 42 1989 155-163
6. Y. Bastion C. Sebban F. Berger et al. Incidence, predictive factors and outcome of lymphoma transformation in follicular lymphoma patients J. Clin. Oncol. 15 1997 1587-1594
7. I.S. Lossos & R. Levy Higher grade transformation of follicular lymphoma: Phenotypic tumor progression associated with diverse genetic lesions Semin. Cancer. Biol. 13 2003 191-202
8. C.A. Sander T. Yano H.M. Clark et al. p53 mutation is associated with progression in follicular lymphomas Blood 82 1993 1994-2004
9. W.F. Symmans R.L. Katz N.G. Ordonez et al. Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation Acta Cytol. 39 1995 673-682
10. H.G. Drexler Review of alterations of the cyclin dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells Leukemia 12 1998 845-859
11. J.G. Herman C.I. Civin J.P. Issa et al. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematologic malignancies Cancer Res 57 1997 837-841
12. K. Gronbaek T. Nedergaardt M.K. Anderson et al. Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: A genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb Leukemia 12 1998 1266-1271
13. A.S. Baur P. Shaw N. Burri et al. Frequent methylation silencing of p15(INK4b)(MTS2) and p16(INK4a)(MTS1) in B-cell and T-cell lymphomas Blood 94 1999 1773-1781
14. K.S.J. Elenitoba-Johnson R.D. Gascyne M.S. Lim et al. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicular center lymphoma Blood 91 1998 4677-4685
15. R. Villuendas M. Sanchez-Beato J.C. Martinez et al. Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression Am. J. Pathol. 153 1998 887-897
16. M. Pinyol F. Cobo S. Bea et al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas Blood 91 1998 2977-2984
17. C.C. Chang B.H. Ye R.S. Chaganti & R. Dalla-Favera BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor Proc. Natl. Acad. Sci. USA 93 1996 6947-6952
18. J.P. Kerckaert C. Deweindt H. Tilly et al. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas Nat. Genet. 5 1993 66-70
19. V.L. Seyfert D. Allman Y. He & L.M. Staudt Transcriptional repression by the proto-oncogene BCL-6 Oncogene 12 1996 2331-2342
20. G. Cattoretti C.C. Chang K. Cechova et al. BCL-6 protein is expressed in germinal-center B cells Blood 86 1995 45-53
21. B.H. Ye G. Cattoretti Q. Shen J. Zhang et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation Nat. Genet. 16 1997 61-170
22. F. Lo Coco B.H. Ye F. Lista et al. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma Blood 83 1994 1757-1759
23. C. Bastard C. Deweindt J.P. Kerckaert et al. LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients Blood 83 1994 2423-2427
24. Z. Szereday B. Csernus M. Nagy et al. Somatic mutation of the 5 noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma Am. J. Pathol. 156 2000 1017-1024
25. T. Akasaka I.S. Lossos & R. Levy Analysis of BCL6 gene translocations in higher grade transformation of follicle center lymphomas (FCL) Blood 98 2001 330a
26. D. Capello U. Vitolo L. Pasqualucci et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia Blood 95 2000 651-659
27. I.S. Lossos R. Warnke & R. Levy BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: Correlation with somatic mutations in the 5′ regulatory region of the BCL-6 gene Leukemia 9 2002 1857-1862
28. I.S. Lossos & R. Levy Higher grade transformation of follicle center lymphoma is associated with somatic mutation of the 5′ noncoding regulatory region of the BCL-6 gene Blood 96 2000 635-639
29. Y. Tsujimoto J. Cossman E. Jaffe & C.M. Croce Involvement of the bcl-2 gene in human follicular lymphoma Science 228 1985 1440-1443
30. Y. Tsujimoto J. Gorham J. Cossman et al. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining Science 229 1985 1390-1393
31. S. Raghoebier L. Broos M.H. Kramer et al. Histological conversion of follicular lymphoma with structural alterations of t(14;18) and immunoglobin genes Leukemia 9 1995 1748-1755
32. A. Matolcsy P. Casali R.A. Warnke & D.M. Knowles Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene Blood 88 1996 3937-3944
33. C. Reed & S. Tanaka Somatic point mutations in the translocated bcl-2 genes of non-Hodgkin's lymphomas and lymphocytic leukemias: implications for mechanisms of tumor progression Leuk. Lymphoma 10 1993 157-163
34. J.A. Martinez-Climent A.A. Alizadeh R. Segraves et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with heterogeneous set of DNA copy number and gene expression alterations Blood 101 2003 3109-3117
35. M. Nagy M. Balazs Z. Adam et al. Genetic instability is associated with histological transformation of follicle center lymphoma Leukemia 14 2000 2142-2148
36. C.E. Nesbit J.M. Tersak & E.V. Prochownik MYC oncogenes and human neoplastic disease Oncogene 18 1999 3004-3016
37. J.M. Adams A.W. Harris C.A. Pinkert et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice Nature 318 1985 533-538
38. L.M. Boxer & C.V. Dang Translocations involving c-myc and c-myc function Oncogene 20 2001 5595-5610
39. F. Bahram N. von der Lehr C. Cetinkaya & L.G. Larsson c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover Blood 95 2000 2104-2110
40. M. Raffeld T. Yano A.T. Hoang et al. Clustered mutations in the transcriptional activation domain of Myc in 8q24 translocated lymphomas and their functional consequences Curr. Top. Microbiol. Immunol. 194 1995 265-272
41. A.T. Hoang B. Lutterbach B.C. Lewis et al. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain Mol. Cell Biol. 15 1995 4031-4042
42. M. Henriksson A. Bakardjiev G. Klein & B. Luscher Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential Oncogene 8 1993 3199-3209
43. P.H. Rao J. Houldsworth K. Dyomina et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma Blood 92 1998 234-240
44. I.S. Lossos A.A. Alizadeh M. Diehn et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or deceased expression of c-myc and its regulated genes Proc. Natl. Acad. Sci. USA 99 2002 7259-7264
45. A. Lopez-Guillermo F. Cabanillas T.I. McDonnell et al. Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma Blood 93 1999 3081-3087
46. B. Johannson F. Mertens & F. Mitelman Cytogenetic evolution patterns in non-Hodgkin's lymphomas Blood 86 1995 3905-3914
47. A.N. Mohamed M. Palutke L. Eisenberg & A. Al-Katib Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variant Cancer Genet. Cytogenet. 126 2001 45-51
48. T. Yano E.S. Jaffe D.L. Longo & M. Raffeld MYC rearrangements in histologically progressed follicular lymphomas Blood 80 1992 758-767
49. J.J. Yunis G. Frizzera M.M. Oken et al. Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer N. Engl. J. Med. 367 1987 79-84
50. J. Whang-Peng T. Knutsen E.S. Jaffe et al. Sequential analysis of 43 patients with non-Hodgkin's lymphoma: Clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies Blood 83 1996 203-216
51. P. Bernell B. Jacobsson & J. Liliemark Gain of chromosome 7 marks the progression from indolent to aggressive follicle centre lymphoma and is a common finding in patients with diffuse large B-cell lymphoma: A study by FISH Br. J. Haematol. 101 1998 487-491
52. D.E. Horsman J.M. Connors T. Pantzar & R.D. Gascoyne Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18) Genes Chromosomes Cancer 30 2001 375-382
53. A. Viardot P. Moller J. Hogel et al. Clinicopathologic correlations of genomic gains and losses in follicular lymphoma J. Clin. Oncol. 20 2002 4523-4530
54. H. Tilly R. Rossi A. Stamatoullas et al. Prognostic value of chromosomal abnormalities in follicular lymphoma Blood 84 1994 1043-1049
55. R.E. Hough J.R. Goepel H.E. Alcock et al. Copy number gain at 12q12-14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma Br. J. Cancer 84 2001 499-503
56. P. Bernell I. Arvidsson & B. Jacobsson Gain of chromosome 7, which marks the progression from indolent to aggressive follicle centre lymphomas, is restricted to the B-lymphoid cell lineage: A study by FISH in combination with morphology and immunocytochemistry Br. J. Haematol. 105 1999 1140-1144
57. M. Schena D. Shalon R.W. Davis & P.O. Brown Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 270 1995 467-470
58. M. Schena D. Shalon R. Heller et al. Parralel human genome analysis: microarray based expression monitoring of 1000 genes Proc. Natl. Acad. Sci. USA 93 1996 10614-10619
59. R. Giuseppe C. Zegar & A. Giordano Advantages and limitations of microarray technology in human cancer Oncogene 22 2003 6497-6507
60. L.M. Staudt Molecular diagnosis of the hematologic malignancies N. Engl. J. Med. 348 2003 1777-1785
61. J. DeRisi L. Penland P.O. Brown et al. Use of a cDNA microarray to analyze gene expression patterns in human cancer Nat. Genet. 14 1996 457-460
62. R.A. Heller M. Schena A. Chai et al. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays Proc. Natl. Acad. Sci. USA 94 1997 2150-2155
63. A.A. Alizadeh M.B. Eisen R.E. Davis et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 2000 503-511
64. A. Rosenwald G. Wright W. Chan et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma N. Engl. J. Med. 346 2002 1937-1947
65. D. Scheinkein Proteasome inhibitors in the treatment of B-cell malignancies Clin. Lymphoma 3 2002 49-55
66. R.E. Davis K.D. Brown U. Siebenlist & L.M. Staudt Constitutive nuclear factor kB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells J. Exp. Med. 194 2001 1861-1874
67. A. Alizadeh et al. The Lymphochip: A specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes Cold Spring Harbor Symp. Quant. Biol. 64 1999 71-78
68. M.A. Shipp K.N. Ross P. Tamayo et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning Nature Med. 8 2002 68-74
69. R.S. Robertorye S.D. Bohling J.W. Morgan et al. Microarray analysis of B-cell lymphoma cell lines with the t(14;18) J. Mol. Diagn. 4 2002 123-136
70. H. Husson E.G. Carideo D. Neuberg et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays Blood 99 2002 282-289
71. K. Offit G. Wong D.A. Filippa et al. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkins lymphoma: Clinical correlations Blood 77 1991 1508-1515
72. J. Whang-Peng T. Knotsen E.S. Jaffe et al. Sequential analysis of 43 patients with non-Hodgkins lymphoma: Clinical correlations with cytogenic, histologic, immunophenotyping and molecular studies Blood 85 1995 203-216
73. G.C. Prendergast Mechanisms of apoptosis by c-Myc Oncogene 18 1999 2967-2987
74. D.W. Felsher A. Zetterberg J. Zhu et al. Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts Proc. Natl. Acad. Sci. USA 97 2000 10544-10548
75. K.S.J. Elenitoba-Johnson S.D. Jenson R.T. Abbott et al. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy Proc. Natl. Acad. Sci. USA 100 2003 7259-7264
76. S. de Vos W.K. Hofmann T.M. Grogan et al. Gene expression profile of serial samples of transformed B-cell lymphomas Lab. Invest. 83 2003 271-285
77. Z. Li S. Van Calcar W.K. Cavenee et al. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells Proc. Natl. Acad. Sci. USA 100 2003 8164-8169
78. H. Shi S. Maier I. Nimmrich et al. Oligonucleotide based microarray for DNA methylation analysis: Principles and applications J. Cell Biochem. 88 2003 138-143
79. V. Santini H.M. Kantarjian & J.P. Issa Changes in DNA methylation in neoplasia: Pathophysiology and therapeutic implications Ann. Int. Med. 134 2001 573-586
80. M. Widschwendter & P.A. Jones The prognostic, predictive, and therapeutic values of DNA methylation in cancer Clin. Res. 8 2002 17-21